Big Pharma’s new (record) deal is sweet music to CROs

[2014-10-25, Nr 3 2014, sid 4]
I recall a time when Big Pharma was seen as the temple of major innovation. As a Swedish undergraduate chemist, I had heard my share of stories about how researchers from Astra created and developed metoprolol (Seloken), terbutaline (Bricanyl) and the fantastic tale of how Ivan Östholm defied corporate instructions and created omeprazole (Losec), which later became the top-selling drug worldwide. Defied instructions…what a rebel!

Läs hela krönikan i Copenhagen Life Science >>